PROXYPHARMA LLB: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PROXYPHARMA LLB
Largest movements
- Cash -€72,710
down €72,710 (-45.7%), from €159,032 to €86,322
mainly Contributions, distributions and other (-€60,000) and Receivables within one year (-€37,261)
- Receivables within one year +€37,261
up €37,261 (+13.9%), from €267,439 to €304,700
of which Other amounts receivable: +€29,449
- Current investments -€20,000
down €20,000 (-13.9%), from €144,130 to €124,130
- Tangible fixed assets -€8,215
down €8,215 (-31.1%), from €26,395 to €18,180
- Trade debts -€33,394
down €33,394 (-32.8%), from €101,778 to €68,385
- Profit (loss) carried forward -€14,704
down €14,704 (-6.5%), from €226,121 to €211,417
- Tax, wage and social debts -€10,499
down €10,499 (-27.4%), from €38,346 to €27,846
of which Taxes: -€12,699
- Reserves -€10,000
down €10,000 (-5.9%), from €168,628 to €158,628
- Debts after one year -€9,953
down €9,953 (-53.7%), from €18,538 to €8,584
- Depreciation -€4,275
down €4,275 (-29.9%), from €14,290 to €10,015
- Gross operating margin -€2,933
down €2,933 (-1.3%), from €219,510 to €216,577
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €776,847 | €707,554 | -€69,293 | -8.9% |
| Fixed assets | 21/28 | €27,326 | €19,111 | -€8,215 | -30.1% |
| Tangible fixed assets | 22/27 | €26,395 | €18,180 | -€8,215 | -31.1% |
| Plant, machinery and equipment | 23 | €3,630 | €2,154 | -€1,476 | -40.7% |
| Furniture and vehicles | 24 | €12,024 | €9,060 | -€2,964 | -24.7% |
| Other tangible fixed assets | 26 | €10,741 | €6,966 | -€3,775 | -35.1% |
| Financial fixed assets | 28 | €931 | €931 | = | 0.0% |
| Current assets | 29/58 | €749,521 | €688,443 | -€61,078 | -8.1% |
| Stocks and contracts in progress | 3 | €169,456 | €169,317 | -€139 | -0.1% |
| Stocks | 30/36 | €169,456 | €169,317 | -€139 | -0.1% |
| Amounts receivable within one year | 40/41 | €267,439 | €304,700 | +€37,261 | +13.9% |
| Trade receivables | 40 | €109,005 | €116,817 | +€7,812 | +7.2% |
| Other amounts receivable | 41 | €158,434 | €187,883 | +€29,449 | +18.6% |
| Current investments | 50/53 | €144,130 | €124,130 | -€20,000 | -13.9% |
| Cash at bank and in hand | 54/58 | €159,032 | €86,322 | -€72,710 | -45.7% |
| Deferred charges and accrued income | 490/1 | €9,463 | €3,974 | -€5,490 | -58.0% |
| Total equity and liabilities | 10/49 | €776,847 | €707,554 | -€69,293 | -8.9% |
| Equity | 10/15 | €557,459 | €532,755 | -€24,704 | -4.4% |
| Contributions | 10/11 | €162,710 | €162,710 | = | 0.0% |
| Reserves | 13 | €168,628 | €158,628 | -€10,000 | -5.9% |
| Distributable reserves | 133 | €168,628 | €158,628 | -€10,000 | -5.9% |
| Profit (loss) carried forward | 14 | €226,121 | €211,417 | -€14,704 | -6.5% |
| Amounts payable | 17/49 | €219,388 | €174,799 | -€44,589 | -20.3% |
| Amounts payable after more than one year | 17 | €18,538 | €8,584 | -€9,953 | -53.7% |
| Financial debts | 170/4 | €18,538 | €8,584 | -€9,953 | -53.7% |
| Amounts payable within one year | 42/48 | €200,850 | €166,184 | -€34,665 | -17.3% |
| Current portion of amounts payable after more than one year | 42 | €9,587 | €9,953 | +€367 | +3.8% |
| Trade debts | 44 | €101,778 | €68,385 | -€33,394 | -32.8% |
| Suppliers | 440/4 | €101,778 | €68,385 | -€33,394 | -32.8% |
| Taxes, remuneration and social security | 45 | €38,346 | €27,846 | -€10,499 | -27.4% |
| Taxes | 450/3 | €14,704 | €2,005 | -€12,699 | -86.4% |
| Remuneration and social security | 454/9 | €23,641 | €25,841 | +€2,200 | +9.3% |
| Other amounts payable | 47/48 | €51,139 | €60,000 | +€8,861 | +17.3% |
| Accrued charges and deferred income | 492/3 | €0 | €30 | +€30 | |
| Remuneration, social security and pensions | 62 | €158,385 | €160,338 | +€1,952 | +1.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,290 | €10,015 | -€4,275 | -29.9% |
| Other operating charges | 640/8 | €2,875 | €3,064 | +€189 | +6.6% |
| Gross operating margin | 9900 | €219,510 | €216,577 | -€2,933 | -1.3% |
| Operating profit (loss) | 9901 | €43,960 | €43,161 | -€799 | -1.8% |
| Financial income | 75/76B | €471 | €10 | -€461 | -97.9% |
| Recurring financial income | 75 | €471 | €10 | -€461 | -97.9% |
| Financial charges | 65/66B | €7,663 | €7,373 | -€290 | -3.8% |
| Recurring financial charges | 65 | €7,663 | €7,373 | -€290 | -3.8% |
| Profit (loss) for the period before taxes | 9903 | €36,768 | €35,798 | -€970 | -2.6% |
| Income taxes | 67/77 | €2,032 | €502 | -€1,530 | -75.3% |
| Profit (loss) for the period | 9904 | €34,736 | €35,296 | +€560 | +1.6% |
| Profit (loss) for the period to be appropriated | 9905 | €34,736 | €35,296 | +€560 | +1.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.